Summan Previous cross-sectional data suggest a positive association between serum cholesterol and brain neoplasms. but the results of cohort studies are inconclusive. There is evidence that in women the growth of meningiomas (Neugut et al., 1989) .
conclusion, in women. irregular variation in the P-lipoprotein level. which is involved in the synthesis of progesterone in the CNS. may enhance oncogenic transformation of astrocytes and meningeal cells: however. transformation of the latter is restricted to vounger women.
Case-control studies suggest a positive association between serum cholesterol concentration and brain neoplasms (Basu et al.. 1974 : Abramson & Kark. 1985 : Neugut et al.. 1989 . but the results of cohort studies are inconclusive (Davey Smith & Shipley. 1989 : Knekt et al.. 1991 : Davey Smith et al.. 1992 ). In the Whitehall study a positive relation between plasma cholesterol and mortality from brain cancer was found among men (Davey Smith & Shipley. 1989) . The latest and largest study so far included 399 deaths from central nervous system (CNS) neoplasms among the participants in the male screening Multiple Risk Factor Intervention Trial (Davey Smith et al.. 1992) . No significant association was found. However. according to one of the case-control studies. the difference in serum cholesterol concentration between subjects with and without brain tumours was significant only among women (Neugut et al., 1989) .
As there is evidence that in women the growth of such brain tumours as meningiomas and astrocytomas depends on the hormonal status (Schipper. 1986 : Roelvink et al.. 1987 . the aim of the present study was to examine the association of benign as well as of malignant CNS tumours with both serum cholesterol and frlipoprotein concentration in men and women. with special emphasis on evaluating the effect of menopausal status on these relations.
Subjects and methods
In 1962-65. 97.468 persons from four Mid-Swedish geographical districts took part in a general health survey conducted among the total population of these areas aged 25 years or older. The participation rate was 77.0%. Details of the recruitment and screening methods used have been given elsewhere (Lindberg et al.. 1991) .
Briefly. the screening examination included measurement of weight. height and laboratory determination of different parameters. Body mass index was calculated as weight (kg) height(m-). All serum analyses were run on the same automatic multiple analyser (AutoChemist). Cholesterol was analysed by the Liebermann-Burchard method (Zak et al.. 1954) and -lipoprotein according to the method of Burstein and Samaille (1959) . Total serum cholesterol values expressed in mg dl-' were recalculated to mmol 1-P' by multiplication by 0.02586. The frlipoprotein values. originally measured in units, were converted to g 1' using a multiplication factor of 0.18 (Burstein & Samaille. 1959) .
For each participant additional information on the socioeconomic status was collected. based on the 1960 national census including 12 socioeconomic groups.
In accordance with a previously used design. survey data were matched with the National Cancer Register in order to identify all new cases of a CNS tumour in the study population during the period 1962 to 1985 (Gatchev et al.. 1993 Using a nested case-control design. for each case five controls (590 men and 555 women) were randomly selected from the whole study population. They were matched for sex, age at screening (5 year groups) and time (year and month) of serum cholesterol and frlipoprotein determination. Kernohan et al. (1949) . the last to neutralise the influence of possible laboratory drift.
Statistical methods
Analysis of variance (ANOVA) was used to examine differences in mean serum cholesterol and P-lipoprotein concentration between the matched cases and controls with adjustment for socioeconomic status and body mass index. The 95% confidence intervals for differences were calculated using a matched design. In order to investigate the possible effect of menopausal status on the studied relationships, women were stratified into two subgroups. The first group included those who were <50 years both at screening and at tumour diagnosis and the second were all > 50 years of age at these occasions. Those subjects who participated in the health survey before the age of 50 years and had a CNS tumour diagnosed after that age were excluded from the subgroup analysis. For comparison. the same analyses were also performed among men. Statistical significance was assumed at P<0.05. All tests were two-sided.
Results
For the patients with benign CNS tumours mean (± s.d.) age at diagnosis did not differ between men (59 ± 13 years) and women (59 ± 12 years). The malignant tumours were diagnosed at a mean age of 58 ± 10 years in men and 60 ± 9 years in women. but this difference was not statistically significant (P = 0.3).
Neither in men nor in women were any statistically significant differences found in the mean serum cholesterol concentration between cases and controls (Table II) . The same was true for P-lipoprotein.
No statistically significant differences were seen in total cholesterol level between cases and controls after separation of the women by age (Table III) . As is further seen in the by a factor of 0.18 (Burstein et al.. 1959) . (Poisson et al., 1984; Riva et al., 1990) . Sex steroids found in the CNS originate from both extraand intracerebral synthesis, but only the latter has been proven for progesterone and its precursors (Baulieu & Robel, 1990) . Astrocytes metabolise progesterone, converting it to various neuroendocrinologically active derivatives, which can interact with the progesterone receptors (Karavolas & Hodges, 1990) . In glial cells the regulative steroid effects could lead to alterations in the hormonal sensitivity and metabolism (McEwen et al., 1982) , and endocrine modulation of brain functions may also play a role for the occurrence of disease .
The opposite direction of the associations between P-lipo- (Baulieu & Robel, 1990) . One could raise the hypothesis that the abnormal steroid regulation at genomic level, induced by the above alterations, is related to oncogenic transformation in the astrocytes. Certainly, steroids of peripheral origin also may participate in this process (Backstr6m, 1990 (Bixo, 1987) could also be of some importance in this respect, because oestrogen can regulate the synthesis of progesterone receptors (McEwen, 1991) , and may in this way influence the progesterone cell uptake. Five years is a reasonable period for exclusion of tumour cases to avoid a preclinical impact on the levels of the studied parameters (Sherwin et al., 1987) . Repeating the analyses after this procedure revealed in both studied subgroups among women statistically significant associations between the total serum cholesterol concentration and the development of a malignant CNS tumour, with the same direction as corresponding P-lipoprotein levels. Alterations in the statistical significance regarding the importance of the P-lipoprotein concentration are most probably due to weakened statistical power as a result of the reduced number of analysed subjects. Adjustment for socioeconomic status, which is a factor that is related to the serum cholesterol level, was performed in all of the previous cohort studies ( Davey Smith & Shipley, 1989; Knekt et al., 1991; Davey Smith et al., 1992) , and in two of them (Davey Smith & Shipley, 1989; Knekt et al., 1991 ) also for body mass index. As in the present investigation, this did not have any impact on the results.
Misclassification of studied astrocytomas owing to histological sampling error would weaken the statistical significance of observed differences between cases and controls. Hence, the observed results occurred despite possible misclassifications and not because of them.
In conclusion, in women, irregular variation in the Plipoprotein level, which is involved in the synthesis of progesterone in the CNS, may enhance oncogenic transforma- 
